HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$0.48
Day range
$0.48 - $0.58
Year range
$0.39 - $11.40
Market cap
51.17M USD
Avg Volume
550.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 344.00K | -82.70% |
Operating expense | -794.00K | -139.31% |
Net income | -16.20M | 34.18% |
Net profit margin | -4.71K | -280.40% |
Earnings per share | -0.20 | 62.02% |
EBITDA | -11.14M | 45.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 46.33M | -33.38% |
Total assets | 54.13M | -33.66% |
Total liabilities | 63.99M | 3.49% |
Total equity | -9.86M | — |
Shares outstanding | 91.78M | — |
Price to book | -4.40 | — |
Return on assets | -65.05% | — |
Return on capital | -115.25% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -16.20M | 34.18% |
Cash from operations | -16.06M | -10.73% |
Cash from investing | 8.00K | 103.52% |
Cash from financing | 39.43M | 146,122.22% |
Net change in cash | 23.37M | 258.32% |
Free cash flow | -11.62M | -54.54% |
About
Founded
2013
Headquarters
Website
Employees
71
